Real-time Estimate
Cboe BZX
17:28:33 30/04/2024 BST
|
5-day change
|
1st Jan Change
|
14.62
USD
|
-0.24%
|
|
-4.19%
|
-30.30%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
537.6
|
967.6
|
743.8
|
469.2
|
850.1
|
603.6
|
-
|
-
|
Enterprise Value (EV)
1 |
485.1
|
810.6
|
631.8
|
407
|
720.2
|
506.1
|
517.2
|
603.6
|
P/E ratio
|
-13.9
x
|
-19.9
x
|
-13
x
|
-7.6
x
|
-18.6
x
|
-14.6
x
|
-19.2
x
|
-45.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.99
x
|
13.2
x
|
8.25
x
|
4.41
x
|
6.12
x
|
3.69
x
|
3.13
x
|
2.73
x
|
EV / Revenue
|
7.21
x
|
11
x
|
7.01
x
|
3.83
x
|
5.19
x
|
3.09
x
|
2.68
x
|
2.73
x
|
EV / EBITDA
|
-13.8
x
|
-21.7
x
|
-12.7
x
|
-7.04
x
|
-41.6
x
|
-44.8
x
|
-151
x
|
40.4
x
|
EV / FCF
|
-14,236,252
x
|
-
|
-
|
-7,955,735
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
8.59
x
|
5.75
x
|
5.57
x
|
4.81
x
|
4.76
x
|
3.81
x
|
3.91
x
|
-
|
Nbr of stocks (in thousands)
|
25,005
|
32,361
|
33,490
|
34,496
|
40,501
|
41,204
|
-
|
-
|
Reference price
2 |
21.50
|
29.90
|
22.21
|
13.60
|
20.99
|
14.65
|
14.65
|
14.65
|
Announcement Date
|
09/03/20
|
08/03/21
|
28/02/22
|
27/02/23
|
26/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
67.3
|
73.39
|
90.15
|
106.4
|
138.9
|
163.6
|
192.8
|
221.5
|
EBITDA
1 |
-35.23
|
-37.44
|
-49.58
|
-57.8
|
-17.3
|
-11.3
|
-3.423
|
14.95
|
EBIT
1 |
-36
|
-38.57
|
-51.67
|
-61.26
|
-46.93
|
-43.05
|
-33.84
|
-13.44
|
Operating Margin
|
-53.5%
|
-52.55%
|
-57.31%
|
-57.57%
|
-33.79%
|
-26.32%
|
-17.56%
|
-6.07%
|
Earnings before Tax (EBT)
1 |
-
|
-43.7
|
-56.57
|
-61.26
|
-43.34
|
-42.17
|
-30.16
|
-13.19
|
Net income
1 |
-38.4
|
-43.7
|
-56.57
|
-61.26
|
-43.34
|
-40.95
|
-31.48
|
-13.46
|
Net margin
|
-57.06%
|
-59.54%
|
-62.75%
|
-57.57%
|
-31.2%
|
-25.04%
|
-16.33%
|
-6.08%
|
EPS
2 |
-1.550
|
-1.500
|
-1.710
|
-1.790
|
-1.130
|
-1.001
|
-0.7629
|
-0.3200
|
Free Cash Flow
|
-34.07
|
-
|
-
|
-51.16
|
-
|
-
|
-
|
-
|
FCF margin
|
-50.63%
|
-
|
-
|
-48.08%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
09/03/20
|
08/03/21
|
28/02/22
|
27/02/23
|
26/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
22.29
|
25.23
|
22.44
|
25.58
|
26.43
|
31.95
|
32.71
|
33.3
|
34.01
|
38.86
|
36.49
|
39.42
|
40.48
|
46.96
|
44.39
|
EBITDA
1 |
-12.61
|
-13.28
|
-16.16
|
-17.09
|
-12.62
|
-10.29
|
-3.939
|
-10.73
|
-3.85
|
-4.811
|
-5.673
|
-3.842
|
-2.533
|
0.7185
|
-2.661
|
EBIT
1 |
-13.2
|
-13.93
|
-16.87
|
-17.88
|
-13.57
|
-11.29
|
-11.29
|
-11.96
|
-11.17
|
-12.51
|
-13.56
|
-11.38
|
-10.32
|
-7.929
|
-9.772
|
Operating Margin
|
-59.23%
|
-55.21%
|
-75.17%
|
-69.89%
|
-51.32%
|
-35.35%
|
-34.53%
|
-35.92%
|
-32.84%
|
-32.18%
|
-37.16%
|
-28.86%
|
-25.5%
|
-16.88%
|
-22.01%
|
Earnings before Tax (EBT)
1 |
-15.87
|
-14.48
|
-17.41
|
-18.51
|
-14.16
|
-11.18
|
-11.12
|
-11.21
|
-10.02
|
-10.98
|
-13.21
|
-11.03
|
-10.08
|
-7.262
|
-9.747
|
Net income
1 |
-15.87
|
-14.48
|
-17.41
|
-18.51
|
-14.16
|
-11.18
|
-11.12
|
-11.21
|
-10.02
|
-10.98
|
-12.93
|
-10.76
|
-9.683
|
-7.338
|
-9.747
|
Net margin
|
-71.22%
|
-57.38%
|
-77.59%
|
-72.36%
|
-53.56%
|
-34.97%
|
-34.01%
|
-33.65%
|
-29.46%
|
-28.26%
|
-35.42%
|
-27.31%
|
-23.92%
|
-15.63%
|
-21.96%
|
EPS
2 |
-0.4800
|
-0.4300
|
-0.5200
|
-0.5400
|
-0.4100
|
-0.3200
|
-0.3200
|
-0.3000
|
-0.2500
|
-0.2700
|
-0.3150
|
-0.2650
|
-0.2362
|
-0.1838
|
-0.2467
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
08/11/21
|
28/02/22
|
09/05/22
|
08/08/22
|
07/11/22
|
27/02/23
|
01/05/23
|
07/08/23
|
06/11/23
|
26/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
52.6
|
157
|
112
|
62.1
|
130
|
97.6
|
86.5
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-34.1
|
-
|
-
|
-51.2
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-50.1%
|
-37.6%
|
-37.3%
|
-52.6%
|
-32.4%
|
-23%
|
-20.5%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.500
|
5.200
|
3.990
|
2.830
|
4.410
|
3.850
|
3.750
|
-
|
Cash Flow per Share
2 |
-1.280
|
-1.060
|
-1.190
|
-1.220
|
-0.4900
|
-0.5100
|
-0.0500
|
-
|
Capex
|
2.45
|
2.56
|
6.39
|
9.51
|
-
|
-
|
-
|
-
|
Capex / Sales
|
3.63%
|
3.49%
|
7.09%
|
8.93%
|
-
|
-
|
-
|
-
|
Announcement Date
|
09/03/20
|
08/03/21
|
28/02/22
|
27/02/23
|
26/02/24
|
-
|
-
|
-
|
Last Close Price
14.65
USD Average target price
26.22
USD Spread / Average Target +78.99% Consensus |
1st Jan change
|
Capi.
|
---|
| -30.30% | 602M | | +73.19% | 12.36B | | -20.84% | 7.83B | | +16.27% | 7.21B | | +4.77% | 5.97B | | +11.77% | 5.14B | | +29.65% | 4.43B | | -18.81% | 3.9B | | -41.51% | 2.2B | | +1.24% | 2.02B |
Medical Equipment
|